Authors: Omura-Minamisawa, M Diccianni, MB Chang, RC Batova, A Bridgeman, LJ Schiff, J Cohn, SL London, WB Yu, AL

Citation: M. Omura-minamisawa et al., p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease, CLIN CANC R, 7(11), 2001, pp. 3481-3490

Authors: Shao, LE Diccianni, MB Tanaka, T Gribi, R Yu, AL Pullen, JD Camitta, BM Yu, J

Citation: Le. Shao et al., Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication, CANCER RES, 61(19), 2001, pp. 7333-7338

Authors: von Lintig, FC Huvar, I Law, P Diccianni, MB Yu, AL Boss, GR

Citation: Fc. Von Lintig et al., Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia, CLIN CANC R, 6(5), 2000, pp. 1804-1810

Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J Pullen, J Bowman, WP Yu, AL

Citation: M. Omura-minamisawa et al., Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia, CLIN CANC R, 6(4), 2000, pp. 1219-1228

Authors: Omura-Minamisawa, M Diccianni, MB Batova, A Chang, RC Bridgeman, LJ Yu, J de Wit, E Kung, FH Pullen, JD Yu, AL

Citation: M. Omura-minamisawa et al., In vitro sensitivity of T-cell lymphoblastic leukemia to UCN-01 (7-hydroxystaurosporine) is dependent on p16 protein status: A pediatric oncology group study, CANCER RES, 60(23), 2000, pp. 6573-6576

Authors: Batova, A Diccianni, MB Omura-Minamisawa, M Yu, J Carrera, CJ Bridgeman, LJ Kung, FH Pullen, J Amylon, MD Yu, AL

Citation: A. Batova et al., Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro, CANCER RES, 59(7), 1999, pp. 1492-1497